NCT01910220View on ClinicalTrials.gov

Study to Assess the Safety and Bioeffect of REGN1033 (SAR391786)

PHASE1CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

October 31, 2014

Conditions
Healthy Volunteers
Interventions
DRUG

REGN1033 (SAR391786)

OTHER

placebo

Trial Locations (5)

Unknown

Gainesville

Orlando

Boston

St Louis

Athens

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Regeneron Pharmaceuticals

INDUSTRY

NCT01910220 - Study to Assess the Safety and Bioeffect of REGN1033 (SAR391786) | Biotech Hunter | Biotech Hunter